# BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
> **ANDA219489** · Abbreviated New Drug Application (Generic) · Sponsor: UNIQUE PHARM · Approved 2026-03-24
## Drug
- **FDA Application Number:** ANDA219489
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Bisoprolol Fumarate
- **Active ingredients:** BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UNIQUE PHARM
- **First approval:** 2026-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219489)
---
*MORVS · CC0 1.0*